Skip to search formSkip to main contentSkip to account menu

Frovatriptan succinate

Known as: 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-,(3R)-, Butanedioate(1:1) 
The succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds… 
National Institutes of Health

Related topics

Related topics

2 relations
frovatriptanfrovatriptan 2.5 MG Oral Tablet [Frova]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Intranasal Drug Delivery of Frovatriptan Succinate-Loaded Polymeric Nanoparticles for Brain Targeting.
2016
2016
Factors associated with frovatriptan response in patients with migraine: A prospective, observational study
Background Almost one-third of patients with migraine do not adequately respond to triptans. We examined factors contributing to… 
2015
2015
Frovatriptan succinate controlled-release granule and preparation method thereof
The invention discloses a frovatriptan succinate controlled-release granule, which is prepared by controlled-release coating an… 
2013
2013
A Stability Indicating Assay Method Development and Validation for the Frovatriptan Succinate Monohydrate by Using UV: A Spectrophotometric Technique
A new simple, reliable, inexpensive, and accurate method was developed for the quantification of Frovatriptan Succinate… 
2013
2013
Preparation, Characterization of Hydrates and Anhydrous Forms of Anti migraine Drug - Frovatriptan Succinate
Frovatriptan succinate (FS) is administrated in monohydrate form. A new dihydrate form of FS is crystallized using acetone and… 
2012
2012
N-Methyl-3-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamides as a novel class of cannabinoid receptors agonists with low CNS penetration.
2010
2010
SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF FROVATRIPTAN SUCCINATE MONOHYDRATE IN BULK AND PHARMACEUTICAL DOSAGE FORMS
IJPT | Sep-2010 | Vol. 2 | Issue No.3 | 565-576 Page 565 ISSN: 0975-766X Available Online through Research Article www.ijptonline… 
2008
2008
Investor malaise stalks UK, European biotech
Review
2004
Review
2004
Frovatriptan succinate, a 5‐HT1B/1D receptor agonist for migraine
Frovatriptan succinate is one of the most recent serotonin receptor agonists to receive FDA, approved labelling for use in the… 
2002
2002
Frovatriptan Vernalis.
Vanguard (now Vernalis) has developed frovatriptan, a selective 5-HT1B/1D partial agonist licensed from GlaxoSmithKline as a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)